शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEEVEREST ORGANICS LTD.· Pharmaceuticals & BiotechnologyHighNeutral
Announced Fri, 14 Aug, 2026 · 16:23 IST

Everest Organics Q1 FY27 results: auditor flags TSPCB compliance issue

Qualified OpinionGoing ConcernResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.7%Reaction day
₹289.00
prior close
₹281.05
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-0.8% vs market
Pharmaceuticals peers, median of 167sector-0.3%-0.4% vs sector

On the reaction day the stock moved 0.8 pts less than Nifty Microcap 250 and 0.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.4
10m
-0.4
15m
-0.4
30m
-0.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.7+0.1-0.8-0.3-0.4
Next day
+10.0+0.5+9.5-0.0+10.1
2d
+2.8-0.1+2.9-0.8+3.5
3d
+6.9+0.4+6.5-0.5+7.4
4d
+3.8+0.7+3.1-0.8+4.5
5d
+3.1+0.9+2.2-0.6+3.8
1w
+5.5+1.1+4.4-0.8+6.3
15d
-6.6+1.6-8.2+1.4-7.9
1m
-12.1-0.7-11.4+0.6-12.7
2m
-13.5-3.2-10.2-4.1-9.4
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 167Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q1 FY27 results: Sales turnover of Rs 4,843 lakhs (Domestic Rs 3,764.83L, Exports Rs 1,078.23L). PAT was Rs 111.34 lakhs vs Rs 140.52 lakhs in Q1 FY26, a YoY decline. EPS Rs 1.15 vs Rs 1.45. Auditors issued a qualified limited review report flagging TSPCB pollution control non-compliance with enhanced production beyond consented capacity, warning of potential going concern impact and closure order risk.

Likely market impact

Auditor qualification and going concern warning over pollution compliance may weigh on the stock. PAT declined about 21% YoY, adding concern.